Home › NDC Lookup › RxCUI directory › RxCUI 2692688

0.05 ML faricimab-svoa 120 MG/ML Prefilled Syringe [Vabysmo] — RxCUI 2692688

Name: 0.05 ML faricimab-svoa 120 MG/ML Prefilled Syringe [Vabysmo] (RxCUI 2692688)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 2692688 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2692688

Official name0.05 ML faricimab-svoa 120 MG/ML Prefilled Syringe [Vabysmo]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asVabysmo 6 MG per 0.05 ML Prefilled Syringe; Vabysmo 6 MG in 0.05 ML Prefilled Syringe; 0.05 ML Vabysmo 120 MG/ML Prefilled Syringe

FDA products mapped1

Package NDCs mapped4

Reported Medicaid activity (SDUD)83,862 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

🕸️ Concept Web — How 0.05 ML faricimab-svoa 120 MG/ML Prefilled Syrin... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 0.05 ML faricimab-svoa 120 MG/ML Prefilled Syringe [Vabysmo] RxCUI 2692688 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Faricimab 2591519 IN
- Faricimab-svoa 2591584 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Vabysmo 2591590 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Faricimab Prefilled Syringe 2692682 SCDF
- Faricimab-svoa Prefilled Syringe 2692683 SCDFP
- Faricimab Injectable Product 2591586 SCDG
- Faricimab-svoa Injectable Product 2660477 SCDGP
- Faricimab Prefilled Syringe [Vabysmo] 2692686 SBDF
- Faricimab-svoa Prefilled Syringe [Vabysmo] 2692687 SBDFP
- Vabysmo Injectable Product 2591592 SBDG
- Prefilled Syringe 721656 DF
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- 0.05 ML faricimab-svoa 120 MG/ML Prefilled Syringe 2692684 SCD
- Faricimab-svoa 120 MG/ML 2591585 SCDC
- Faricimab-svoa 120 MG/ML [Vabysmo] 2591591 SBDC

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

0.05 ML faricimab-svoa 120 MG/ML Prefilled Syringe SCD · 2692684
Faricimab-svoa 120 MG/ML SCDC · 2591585
Faricimab Prefilled Syringe SCDF · 2692682
Faricimab-svoa Prefilled Syringe SCDFP · 2692683
Faricimab Injectable Product SCDG · 2591586
Faricimab-svoa Injectable Product SCDGP · 2660477

Brand-Name Concepts

Faricimab-svoa 120 MG/ML [Vabysmo] SBDC · 2591591
Faricimab Prefilled Syringe [Vabysmo] SBDF · 2692686
Faricimab-svoa Prefilled Syringe [Vabysmo] SBDFP · 2692687
Vabysmo Injectable Product SBDG · 2591592
Vabysmo BN · 2591590

📦 FDA Products & Package NDCs

1 product · 4 package NDCs

4 package NDCs map to RxCUI 2692688 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
50242-0096-01	1 VIAL in 1 CARTON (50242-096-01) / .05 mL in 1 VIAL (50242...	VABYSMO	Genentech, Inc.	2022-01-28
50242-0096-06	1 SYRINGE in 1 CARTON (50242-096-06) / .05 mL in 1 SYRINGE	VABYSMO	Genentech, Inc.	2024-07-03
50242-0096-45	1 SYRINGE in 1 CARTON (50242-096-45) / .05 mL in 1 SYRINGE	VABYSMO	Genentech, Inc.	2024-07-03
50242-0096-86	1 VIAL in 1 CARTON (50242-096-86) / .05 mL in 1 VIAL (50242...	VABYSMO	Genentech, Inc.	2022-01-28

Observed labelers: Genentech, Inc. (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J2777	Inj, faricimab-svoa, 0.1mg	2	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.